Robert Morgan

Vice President Regulatory Affairs at Purespring Therapeutics - The London Bioscience Innovation Centre Londo, N/A, gb

Robert Morgan's Contact Details
HQ
N/A
Location
Hook,England,RG27,United Kingdom
Company
Purespring Therapeutics
Robert Morgan's Company Details
Purespring Therapeutics logo, Purespring Therapeutics contact details

Purespring Therapeutics

The London Bioscience Innovation Centre Londo, N/A, gb • 20 - 49 Employees
BioTech/Drugs

Purespring, which launched in November 2020 with £45 million of funding from Syncona Ltd, is the first company to be directly targeting the podocyte, a specialized kidney cell implicated in many kidney diseases, through AAV gene therapy. This approach is based on the work of Professor Moin Saleem, Professor of Paediatric Renal Medicine at the University of Bristol, where he heads a world leading group researching glomerular diseases.

Biotechnology
Details about Purespring Therapeutics
Frequently Asked Questions about Robert Morgan
Robert Morgan currently works for Purespring Therapeutics.
Robert Morgan's role at Purespring Therapeutics is Vice President Regulatory Affairs.
Robert Morgan's email address is ***@purespringtx.com. To view Robert Morgan's full email address, please signup to ConnectPlex.
Robert Morgan works in the Research industry.
Robert Morgan's colleagues at Purespring Therapeutics are Aikaterini Papagianni, Yaseen Mohammed, Roma Muccio, Martin Madill, Alan Ph.D, Marzena Murawska, Katy Linkens and others.
Robert Morgan's phone number is N/A
See more information about Robert Morgan